arrow_back Trending Legislation
Share share

Improved Access to Non-Opioid Pain Management Drugs in Medicare

This act aims to improve access to non-opioid pain management drugs for Medicare beneficiaries. This means citizens will have more options for treating post-surgical and acute pain, potentially helping to combat opioid addiction. Changes include lower costs and no prior authorization requirements for these medications.
Key points
No deductible for qualifying non-opioid pain management drugs starting January 1, 2025.
Non-opioid pain management drugs will be placed on the lowest cost-sharing tier in Medicare Part D.
Prohibition of step therapy and prior authorization requirements for non-opioid pain management drugs.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Alternatives to PAIN Act
Print number: HR 7142
Sponsor: Rep. Miller-Meeks, Mariannette [R-IA-1]
Process start date: 2024-01-30
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Improved Access to Non-Opioid Pain Management Drugs in Medicare

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 7142.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-01-30.

What are the main provisions?

Key points include:

  • No deductible for qualifying non-opioid pain management drugs starting January 1, 2025.
  • Non-opioid pain management drugs will be placed on the lowest cost-sharing tier in Medicare Part D.
  • Prohibition of step therapy and prior authorization requirements for non-opioid pain management drugs.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Miller-Meeks, Mariannette [R-IA-1].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

Analysis and Potential Impact of HR 7142

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health